174 related articles for article (PubMed ID: 17328794)
1. Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer.
Ulazzi L; Sabbioni S; Miotto E; Veronese A; Angusti A; GafĂ R; Manfredini S; Farinati F; Sasaki T; Lanza G; Negrini M
Mol Cancer; 2007 Feb; 6():17. PubMed ID: 17328794
[TBL] [Abstract][Full Text] [Related]
2. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
[TBL] [Abstract][Full Text] [Related]
4. Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines.
Imura M; Yamashita S; Cai LY; Furuta J; Wakabayashi M; Yasugi T; Ushijima T
Cancer Lett; 2006 Sep; 241(2):213-20. PubMed ID: 16303245
[TBL] [Abstract][Full Text] [Related]
5. Identification of PRTFDC1 silencing and aberrant promoter methylation of GPR150, ITGA8 and HOXD11 in ovarian cancers.
Cai LY; Abe M; Izumi S; Imura M; Yasugi T; Ushijima T
Life Sci; 2007 Mar; 80(16):1458-65. PubMed ID: 17303177
[TBL] [Abstract][Full Text] [Related]
6. Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features.
Sathyanarayana UG; Padar A; Suzuki M; Maruyama R; Shigematsu H; Hsieh JT; Frenkel EP; Gazdar AF
Clin Cancer Res; 2003 Dec; 9(17):6395-400. PubMed ID: 14695140
[TBL] [Abstract][Full Text] [Related]
7. Adenomatous polyposis coli 1A is likely to be methylated as a passenger in human gastric carcinogenesis.
Hosoya K; Yamashita S; Ando T; Nakajima T; Itoh F; Ushijima T
Cancer Lett; 2009 Nov; 285(2):182-9. PubMed ID: 19527921
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of the expression of the novel stem cell marker CDCP1 in cancer cells.
Ikeda JI; Morii E; Kimura H; Tomita Y; Takakuwa T; Hasegawa JI; Kim YK; Miyoshi Y; Noguchi S; Nishida T; Aozasa K
J Pathol; 2006 Sep; 210(1):75-84. PubMed ID: 16823897
[TBL] [Abstract][Full Text] [Related]
9. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
10. Identification of 27 5' CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers.
Hagihara A; Miyamoto K; Furuta J; Hiraoka N; Wakazono K; Seki S; Fukushima S; Tsao MS; Sugimura T; Ushijima T
Oncogene; 2004 Nov; 23(53):8705-10. PubMed ID: 15467763
[TBL] [Abstract][Full Text] [Related]
11. Silencing of bidirectional promoters by DNA methylation in tumorigenesis.
Shu J; Jelinek J; Chang H; Shen L; Qin T; Chung W; Oki Y; Issa JP
Cancer Res; 2006 May; 66(10):5077-84. PubMed ID: 16707430
[TBL] [Abstract][Full Text] [Related]
12. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis.
Capo-Chichi CD; Smith ER; Yang DH; Roland IH; Vanderveer L; Cohen C; Hamilton TC; Godwin AK; Xu XX
Cancer; 2002 Oct; 95(8):1802-15. PubMed ID: 12365030
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of integrin alpha4 gene in human gastric cancer cells.
Park J; Song SH; Kim TY; Choi MC; Jong HS; Kim TY; Lee JW; Kim NK; Kim WH; Bang YJ
Oncogene; 2004 Apr; 23(19):3474-80. PubMed ID: 14990990
[TBL] [Abstract][Full Text] [Related]
14. Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors.
Sato H; Suzuki H; Toyota M; Nojima M; Maruyama R; Sasaki S; Takagi H; Sogabe Y; Sasaki Y; Idogawa M; Sonoda T; Mori M; Imai K; Tokino T; Shinomura Y
Carcinogenesis; 2007 Dec; 28(12):2459-66. PubMed ID: 17675336
[TBL] [Abstract][Full Text] [Related]
15. Nidogen-1 and nidogen-2 in healthy human cartilage and in late-stage osteoarthritis cartilage.
Kruegel J; Sadowski B; Miosge N
Arthritis Rheum; 2008 May; 58(5):1422-32. PubMed ID: 18438862
[TBL] [Abstract][Full Text] [Related]
16. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
Wischnewski F; Friese O; Pantel K; Schwarzenbach H
Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
[TBL] [Abstract][Full Text] [Related]
17. Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas.
Furuta J; Nobeyama Y; Umebayashi Y; Otsuka F; Kikuchi K; Ushijima T
Cancer Res; 2006 Jun; 66(12):6080-6. PubMed ID: 16778180
[TBL] [Abstract][Full Text] [Related]
18. Aberrant CBFA2T3B gene promoter methylation in breast tumors.
Bais AJ; Gardner AE; McKenzie OL; Callen DF; Sutherland GR; Kremmidiotis G
Mol Cancer; 2004 Aug; 3():22. PubMed ID: 15301688
[TBL] [Abstract][Full Text] [Related]
19. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation.
Tang H; Goldberg E
J Androl; 2009; 30(2):157-67. PubMed ID: 18930904
[TBL] [Abstract][Full Text] [Related]
20. Aberrant up-regulation of LAMB3 and LAMC2 by promoter demethylation in gastric cancer.
Kwon OH; Park JL; Kim M; Kim JH; Lee HC; Kim HJ; Noh SM; Song KS; Yoo HS; Paik SG; Kim SY; Kim YS
Biochem Biophys Res Commun; 2011 Mar; 406(4):539-45. PubMed ID: 21345334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]